# FDA 483 - MSN Laboratories Private Limited, Unit-II - March 22, 2024

Source: https://www.keypedia.com/records/483/msn-laboratories-private-limited-unit-ii/2086fcb4-ba6f-4b62-91be-759d5efa8f51

> FDA 483 for MSN Laboratories Private Limited, Unit-II on March 22, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: MSN Laboratories Private Limited, Unit-II
- Inspection Date: 2024-03-22
- Product Type: drugs
- Office Name: New England District Office
- Summary: An FDA inspection of MSN Laboratories Private Limited, Unit-II in Sangareddy, India, from March 18-22, 2024, identified a significant issue with facility maintenance. The firm failed to properly maintain buildings and facilities used in API manufacturing in a clean condition. This was evidenced by observations of water staining and unknown residue on ceiling tiles and baseboards in various sample storage rooms.

## Related Officers

- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)

Company: https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144